VBI Vaccines, Inc. is a biopharmaceutical company. It develops technologies which seek to expand vaccine protection during storage or shipment. The Company's eVLP vaccine platform allows for the design of enveloped (e) virus-like particle (VLP) vaccines that closely mimic the target virus. The company's second platform is a thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines, Inc., formerly known as Paulson Capital Corp., is headquartered in Cambridge, Massachusetts.